Detalhe da pesquisa
1.
Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy.
Mol Ther
; 32(6): 1849-1874, 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38584391
2.
Mucosal-associated invariant T cells for cancer immunotherapy.
Mol Ther
; 31(3): 631-646, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463401
3.
Interleukin 15 in Cell-Based Cancer Immunotherapy.
Int J Mol Sci
; 23(13)2022 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35806311
4.
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method.
Nat Biotechnol
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744947
5.
Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering.
Nat Commun
; 14(1): 6942, 2023 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37938576
6.
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy.
Cancers (Basel)
; 14(9)2022 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35565395
7.
Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity.
Cancers (Basel)
; 14(11)2022 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681730